Newsroom

Views and missives from the frontier

All
  • Perspectives
  • In the News
  • Videos
    • In the News
    Boston Globe

    Cambridge startup CAMP4 Therapeutics raises $100 million for RNA therapies

    In the News
    BioCentury

    Patient Square’s Enavate backs Camp4 in $100M series B, driving push to clinic

    In the News
    Business Insider

    See the 18-slide pitch deck a genetics startup used to raise $100 million and explore ‘the dark side’ of the genome

    In the News
    Endpoints

    With a fresh $100M in hand, one RNA startup is moving to the clinic, finding partners and building a new lab — all at once

    In the News
    Fierce Biotech

    Equipped with fresh $100M, CAMP4 heads up trail to the clinic, hoping partners will soon tag along

    In the News
    Timmerman Report

    CAMP4 Raises $100M to Drug ‘the Dark Side of the Genome’

    In the News
    Scrip

    CAMP4 Charts A Different Course In RNA-Based Therapeutics

    In the News
    BioSpace

    CAMP4 Brings $100M to Target the Dark Side of the Genome with regRNA Platform

    Media Contact:
    PR@camp4tx.com

    Top